Biofrontera (BFRI) Cash & Current Investments (2020 - 2025)

Biofrontera's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $6.4 million for Q4 2025.

• On a quarterly basis, Cash & Current Investments rose 8.41% year-over-year to $6.4 million in Q4 2025; TTM through Dec 2025 was $6.4 million, a 8.41% increase from a year earlier, with the FY2025 full-year figure at $6.4 million, up 8.41% from the prior year.
• Cash & Current Investments improved to $6.4 million in Q4 2025 per BFRI's latest filing, from $3.4 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $31.9 million in Q2 2022 and bottomed at $1.4 million in Q4 2023.
• The 5-year median for Cash & Current Investments is $6.4 million (2025), against an average of $11.1 million.
• Across the five-year window, Cash & Current Investments jumped 1502.56% in 2022 and sank 94.88% in 2023, its largest moves.
• Year by year, Cash & Current Investments stood at $24.5 million in 2021, then increased by 13.29% to $27.8 million in 2022, then sank by 94.88% to $1.4 million in 2023, then soared by 316.05% to $5.9 million in 2024, then climbed by 8.41% to $6.4 million in 2025.
• Per Business Quant, the three latest BFRI Cash & Current Investments figures stand at $6.4 million (Q4 2025), $3.4 million (Q3 2025), and $7.2 million (Q2 2025).